Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence
about
Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infectionAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerCurrent Cervical Carcinoma Screening GuidelinesAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.New strategies for human papillomavirus-based cervical screeningEurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer.Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.A portrait of single and multiple HPV type infections in Brazilian women of different age strata with squamous or glandular cervical lesionsOVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.Interactome analysis of gene expression profiles of cervical cancer reveals dysregulated mitotic gene clusters.Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studiesUpdate on prevention and screening of cervical cancer.An updated natural history model of cervical cancer: derivation of model parameters.Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical NeoplasiasHuman papillomavirus infection in women with and without cervical cancer in Ibadan, NigeriaLower cost strategies for triage of human papillomavirus DNA-positive women.HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: optimization by different ways of sequence rearrangements (shuffling).Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.Significance of HPV-58 infection in women who are HPV-positive, cytology-negative and living in a country with a high prevalence of HPV-58 infection.A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening resultsAge-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA testA long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancerChanges in type-specific human papillomavirus load predict progression to cervical cancer.The known unknowns of HPV natural history.The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.How might HPV testing be integrated into cervical screening?Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.High-risk HPV infection after five years in a population-based cohort of Chilean women.Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
P2860
Q24568227-2FB15A57-D61A-4E46-92B1-391FE3ACA64AQ24607403-336FDE1D-91CD-47A9-BE9A-38B43675555DQ26799522-9D5CBADE-BF7E-4BF6-A617-CE610A8A2EC8Q26828840-87C39A72-E299-46C8-9012-14E83685AD3EQ26851699-AD55B492-2C91-4739-9EBB-98E0F1C6FD12Q30251868-D191118C-C4AB-4732-A3CA-3C434D610D6CQ30278596-1E82A7CD-D725-490D-88B7-D20EB82E21FBQ30352388-304B2A75-855D-4970-A703-DAA0848A6D90Q30388952-09F1EB1C-E50C-490E-A2B0-4AB165F6B582Q30658080-55C5B1C5-89EC-49E0-9264-C32B7832282DQ33589259-921C45E3-7EB1-43CC-BEAA-75EBA75808A4Q33608013-0034D7FD-BE5D-406B-B970-34EAFDCDD6B1Q33685023-D635B45B-6D1B-49EF-B295-62FFF3D838BDQ33850340-A8E44DF7-5BE8-4D54-844E-616B2EFCBB7FQ33891821-9EFF76A4-BEC2-4F9F-BE14-A7CCC355A8EDQ34031269-60CE873C-F119-4EBA-9D54-9A4C1252E552Q34083083-612288E4-5C1B-4CCE-9100-219E8D94CC52Q34286142-6D363A6E-FB90-489D-B69D-586499316922Q34432811-30D8E297-B699-42B2-8CDA-C1F99BDF149EQ34471165-78831F53-8A2B-4F71-B297-675C09A94AD3Q34516596-FB86BF53-8878-4A32-9A4C-B99C7D0F5509Q34535660-C5CE2E49-A3C1-452D-9E5A-8D33C1800D18Q34571825-82E0B7E6-FDC6-433D-99D0-0363BF8E3551Q34608714-BE266B3D-B7A9-4803-A8F5-B8FC85F11C6FQ34622565-7FC2249E-8391-49AA-B4D9-25573F7DEAF6Q34625983-25536077-4E77-43C3-9280-496DF64569DCQ34916671-E343F73D-173E-41B9-8C8E-0590F8F0D68CQ35039759-715A1B63-286F-4835-BF02-8B2B253DA343Q35066980-5EA81F5C-FA20-4C89-A852-08E5D922910BQ35088687-7F00C1E3-459F-4C78-A995-421B24A215CBQ35140046-E1306D75-3D29-404E-B468-2C1B21AB1056Q35164373-B0B38CC6-BDEB-44D3-8B2A-A91DFFB2B8BAQ35223393-34C88A83-4EA6-45C0-8FC4-58C29D2E15E7Q35370456-7DEEFE7D-9CAD-4692-8F84-591B517DBB18Q35578583-C53018F7-A96B-435E-B31B-4C8CABE1F19AQ35588255-A7F47E38-ADB6-4097-83E0-786293553749Q35661312-3C2386E6-16CF-4D8E-ABB8-B1F78523C131Q35665790-0B949372-41A1-4B3F-8384-946283D3AB08Q35721263-DBBE7AD4-A78A-483F-87EA-642275A5F1E6Q35738881-3CAAAA80-EC26-4407-9AF5-84E8E77D4C52
P2860
Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term absolute risk of cer ...... infection: role of persistence
@ast
Long-term absolute risk of cer ...... infection: role of persistence
@en
Long-term absolute risk of cer ...... infection: role of persistence
@nl
type
label
Long-term absolute risk of cer ...... infection: role of persistence
@ast
Long-term absolute risk of cer ...... infection: role of persistence
@en
Long-term absolute risk of cer ...... infection: role of persistence
@nl
prefLabel
Long-term absolute risk of cer ...... infection: role of persistence
@ast
Long-term absolute risk of cer ...... infection: role of persistence
@en
Long-term absolute risk of cer ...... infection: role of persistence
@nl
P2093
P2860
P356
P1476
Long-term absolute risk of cer ...... infection: role of persistence
@en
P2093
Christian Munk
Kirsten Frederiksen
Susanne K Kjær
Thomas Iftner
P2860
P304
P356
10.1093/JNCI/DJQ356
P407
P577
2010-09-14T00:00:00Z